Navigation Links
Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
Date:3/28/2011

halon sells more than 150 products in nearly 100 countries.  More information on Cephalon and its products is available at http://www.cephalon.com/.

About ChemGenex Pharmaceuticals LimitedChemGenex is an oncology focused biopharmaceutical company developing small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs.  A New Drug Application is in preparation for submission to the U.S. Food and Drug Administration in H2 2011 for omacetaxine in CML patients who have failed two or more currently approved tyrosine kinase inhibitors. A parallel Marketing Authorisation Application is in preparation for submission to the European Medicines Agency in H2 2011. ChemGenex has established a corporate alliance with Hospira Inc. to develop and commercialize omacetaxine in Europe, the Middle East and parts of Africa, and is seeking to establish commercial partnerships in the rest of the world.  ChemGenex plans to commercialize omacetaxine itself in North America. ChemGenex trades on the Australian Stock Exchange under the symbol "CXS". For additional information on ChemGenex Pharmaceuticals, please visit the company's website at http://www.chemgenex.com.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements in relation to Cephalon or ChemGenex.  Forward-looking statements provide current expectations or forecasts of future events.  These may include statements regarding anticipated scientific progress on research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for products, sales and earnings guidance, and other statements regarding matters that are not historical facts.  You may identify some of t
'/>"/>

SOURCE Cephalon, Inc.; ChemGenex Pharmaceuticals Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Cephalon Wins FENTORA Patent Suit Against Watson
2. Cephalon Announces Definitive Agreement to Acquire Gemin X
3. Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
4. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
5. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
6. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
7. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
8. Cephalon to Webcast Investor Day
9. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
10. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
11. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...
(Date:5/20/2013)... GLENWOOD, Ill. , May 20, 2013 ... leader in personal and environmental radiation measurement and monitoring, ... accessories, announced today that its Board of Directors declared, ... quarterly cash dividend of $0.55 per share for the ... paid on July 3, 2013, to shareholders of record ...
(Date:5/20/2013)... , May 20, 2013   National Community Pharmacists ... , RPh, MBA issued the following statement today ... regarding Medicare Part D "preferred pharmacy" drug plans ... patients the plan,s lowest advertised co-payments: (Logo:  ... Medicare and MedPAC , 16 U.S. ...
Breaking Medicine Technology:North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4Landauer, Inc. Declares Regular Cash Dividend 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4
... (Nasdaq CM: SPEX), an innovator in biotechnology for ... providers of technical and regulatory consulting services to ... that the Company,s pharmaceutical product, D-tagatose, has been ... promising cardiovascular/metabolic therapies in development.  The selection was ...
... a developer and manufacturer of ultrahigh-brightness light sources for ... a clean manufacturing facility at its Massachusetts location. The ... assembly capability that will be used for optics assembly ... "Our new clean manufacturing space will give ...
Cached Medicine Technology:Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 2Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 3Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 4Energetiq Technology Implements Clean Manufacturing 2
(Date:5/21/2013)... Dimensional Insight, a developer of business intelligence ... Maryland Health System, a 275-bed hospital based in ... to help it analyze its data more quickly. Western ... Diver through Dimensional Insight’s recently announced partnership with ... Maryland has massive amounts of data in disparate systems, ...
(Date:5/21/2013)... AAG Health, the leading age management ... that it has acquired the OligoScan test made by ... advanced spectrophotometry technology, the OligoScan device is capable of ... 14 heavy metals, 20 trace elements (minerals), and oxidative ... substances such as mercury, lead, aluminum, and arsenic, will ...
(Date:5/21/2013)... ATS 2013, PHILADELPHIA The surgical management of non-small ... depending on the race of the patient, according to ... for Stage I and Stage II NSCLC is surgery," ... Medical Center in Omaha, Nebraska. "In our study of ... hospitals between the years 2000 and 2010, we found ...
(Date:5/21/2013)... After the success of its inaugural 1,000 ... Fit Body Boot Camp Goderich will be hosting its 2nd ... Goderich fitness center located at 199 Anglesea Street ... Challenge’s goal is to inspire and motivate local community residents ... The fee to participate is discounted to $40 for ...
(Date:5/21/2013)... Verdasys today announced availability ... (MSCD), a fully managed, outsourced service for companies ... malware and persistent cyber attacks from stealing sensitive data. ... data protection platform by making it available via a ... data transactions and systems events as well as data ...
Breaking Medicine News(10 mins):Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 2Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 3Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 4
... (NYSE: HB ) today announced its fiscal 2008 ... declared by Hillenbrand,s,Board of Directors on February 7, 2008, ... record at the close of business on March 17, ... is organized into two operating companies,serving the health care ...
... 6 times more likely to make mistakes , , FRIDAY, ... are about six times more likely to make medication errors ... a 123 pediatric residents at three children,s hospitals in the ... residents were depressed, and 74 percent were burned out. During ...
... CJPS Enterprises, LLC, (http://www.cjps-enterprises.com ) announced that it ... and licensing of intellectual property (IP)., The ... already,making its website available to universities, research organizations, ... "You have,to fill the shelves of the store ...
... Oversee Phase 3 Program of CGT-2168, ... Pharmaceuticals,Inc., today named a distinguished international panel ... Steering Committee charged with overseeing COGENT,the company,s ... its novel,combination antiplatelet product CGT-2168., (Logo: ...
... Mylan Inc. (NYSE: MYL ),today announced that Mylan ... judge in Florida finding that the inclusion of,Levothyroxine Sodium ... of legislative authority and that the product should be ... products available to pharmacies in Florida as soon,as motions ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
Cached Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... multi-drug test device provides clear, ... Negative results can be determined ... minutes; positive results require only ... urine sample application will dependably ...
... abuse tests are highly accurate in detecting the ... as confirmed by GC/MS testing. The assay provides ... method (such as GC/MS) must be used in ... should be applied to any drug of abuse ...
Medicine Products: